Optimising combined treatment for migraine and temporomandibular disorders (TMDs)

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Cephalalgia

• Publication date

  2025-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/03331024251368882PMID 40936448
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of temporomandibular disorder comorbidity on pain, quality of life, sleep, and functional outcomes in chronic migraine patients not using preventive treatment: a cross-sectional study

  2025cited by this paper
• Temporomandibular disorders patients with migraine symptoms have increased disease burden due to psychological conditions

  2025cited by this paper
• Standardised Tool for the Assessment of Bruxism: Translation, Cultural Adaptation and Pilot Testing in Italy

  2024cited by this paper
• Orofacial Pain

  2024cited by this paper
• Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine

  2024cited by this paper
• Global Prevalence of Sleep Bruxism and Awake Bruxism in Pediatric and Adult Populations: A Systematic Review and Meta-Analysis

  2024cited by this paper
• European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol

  2024cited by this paper
• Bruxism, temporomandibular disorders, and headache-a narrative review of correlations and causalities.

  2024cited by this paper
• Does combining oro-facial manual therapy with bruxism neuroscience education affect pain and function in cases of awake bruxism? A pilot study.

  2024cited by this paper
• Temporomandibular disorders in migraine and tension-type headache patients: a systematic review with meta-analysis

  2024cited by this paper
• The effectiveness of botulinum toxin for temporomandibular disorders: A systematic review and meta-analysis

  2024cited by this paper
• Temporomandibular Disorders, Bruxism and Headaches.

  2024cited by this paper
• Calcitonin gene‐related peptide‐targeting therapies are a first‐line option for the prevention of migraine: An American Headache Society position statement update

  2024cited by this paper
• One session of repetitive transcranial magnetic stimulation induces mild and transient analgesic effects among female individuals with painful temporomandibular disorders.

  2024cited by this paper
• Temporomandibular Joint Disorder Comorbidities.

  2023cited by this paper
• Medication overuse headache

  2023cited by this paper
• Pharmacological Management of Orofacial Pain

  2023cited by this paper
• The Efficacy of Physical Therapy and Rehabilitation Approaches in Chronic Migraine: A Systematic Review and Meta-Analysis.

  2023cited by this paper
• An Update on Temporomandibular Disorders (TMDs) and Headache

  2023influential reference
• Standardized Tool for the Assessment of Bruxism (STAB).

  2023cited by this paper
• European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptyline

  2023cited by this paper
• Effectiveness of Different Electrical Stimulation Modalities for Pain and Masticatory Function in Temporomandibular Disorders: A Systematic Review and Meta-Analysis.

  2023cited by this paper
• Global epidemiology of migraine and its implications for public health and health policy

  2023cited by this paper
• Applying a biopsychosocial model to migraine: rationale and clinical implications

  2022cited by this paper
• Are central sensitization symptoms and psychosocial alterations interfering in the association between painful TMD, migraine, and headache attributed to TMD?

  2022cited by this paper
• Current Knowledge and Future Perspectives on Awake Bruxism Assessment: Expert Consensus Recommendations

  2022cited by this paper
• A rose by another name? Characteristics that distinguish headache secondary to temporomandibular disorder from headache that is comorbid with TMD.

  2022cited by this paper
• Association among headache, temporomandibular disorder, and awake bruxism: A cross‐sectional study

  2022cited by this paper
• Temporomandibular disorder and headache prevalence: A systematic review and meta-analysis

  2022cited by this paper
• Interplay of Oral, Mandibular, and Facial Disorders and Migraine

  2022influential reference
• Botulinum Toxin for Treating Temporomandibular Disorders: What is the Evidence?

  2022cited by this paper
• High Precision Use of Botulinum Toxin Type A (BONT-A) in Aesthetics Based on Muscle Atrophy, Is Muscular Architecture Reprogramming a Possibility? A Systematic Review of Literature on Muscle Atrophy after BoNT-A Injections

  2022cited by this paper
• The association between specific temporomandibular disorders and cervicogenic headache.

  2021cited by this paper
• Association between primary headaches and temporomandibular disorders: A systematic review and meta-analysis.

  2021cited by this paper
• The Prevalence and Overlaps of Temporomandibular Disorders in Patients with Myofascial Pain with Referral—A Pilot Study

  2021cited by this paper
• Tension-type headache

  2021cited by this paper
• Pain in the temple? Headache, muscle pain or both: A retrospective analysis

  2021cited by this paper
• The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice

  2021cited by this paper
• Association Between Primary Headache and Bruxism: An Updated Systematic Review.

  2021cited by this paper
• Reduction of headache intensity and frequency with maxillary stabilization splint therapy in patients with temporomandibular disorders-headache comorbidity: a systematic review and meta-analysis

  2021cited by this paper
• Sleep Bruxism and Temporomandibular Disorders: a scoping review of the literature.

  2021cited by this paper
• Acute Migraine Treatment

  2021cited by this paper
• Clinical, psychological, and sensory characteristics associated with headache attributed to temporomandibular disorder in people with chronic myogenous temporomandibular disorder and primary headaches

  2021cited by this paper
• Intraoral appliances for temporomandibular disorders: what we know and what we need to know

  2021cited by this paper
• Bruxism in Acute Neurologic Illness

  2021cited by this paper
• Bruxism definition: Past, present, and future - What should a prosthodontist know?

  2021cited by this paper
• Temporomandibular disorders: a review of current concepts in aetiology, diagnosis and management.

  2020cited by this paper
• International Classification of Orofacial Pain, 1st edition (ICOP)

  2020cited by this paper
• Experimental Pain Sensitivity in Subjects with Temporomandibular Disorders and Multiple Other Chronic Pain Conditions: The OPPERA Prospective Cohort Study.

  2020cited by this paper
• Clinical Characteristics of Pain Among Five Chronic Overlapping Pain Conditions.

  2020cited by this paper
• Preclinical studies investigating the neural mechanisms involved in the co‐morbidity of migraine and temporomandibular disorders: the role of CGRP

  2020cited by this paper
• Medications and addictive substances potentially inducing or attenuating sleep bruxism and/or awake bruxism

  2020cited by this paper
• Orofacial pain, the 12th specialty: The necessity.

  2020cited by this paper
• Bruxism: a summary of current knowledge on aetiology, assessment and management

  2020cited by this paper
• Medication-overuse headache

  2020cited by this paper
• Efficacy and safety of propranolol for treatment of TMD pain: a randomized, placebo-controlled clinical trial.

  2020cited by this paper
• Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study

  2020cited by this paper
• Evaluation of Relationship Between Sleep Bruxism and Headache Impact Test-6 (HIT-6) Scores: A Polysomnographic Study

  2019cited by this paper
• The diagnostic accuracy of headache measurement instruments: A systematic review and meta-analysis focusing on headaches associated with musculoskeletal symptoms

  2019cited by this paper
• Facial presentations of migraine, TACs, and other paroxysmal facial pain syndromes

  2019cited by this paper
• Physical therapy and migraine: musculoskeletal and balance dysfunctions and their relevance for clinical practice.

  2019influential reference
• Long-term changes in biopsychosocial characteristics related to temporomandibular disorder: findings from the OPPERA study

  2018cited by this paper
• Effects of a Physical Therapy Protocol in Patients with Chronic Migraine and Temporomandibular Disorders: A Randomized, Single-Blinded, Clinical Trial.

  2018cited by this paper
• Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study

  2018cited by this paper
• Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

  2018influential reference
• International consensus on the assessment of bruxism: Report of a work in progress

  2018cited by this paper
• Myofascial trigger points in migraine and tension-type headache

  2018cited by this paper
• Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders.

  2017cited by this paper
• Clinical outcomes of Botox injections for chronic temporomandibular disorders: do we understand how Botox works on muscle, pain, and the brain?

  2017cited by this paper
• Temporal change in headache and its contribution to the risk of developing first-onset temporomandibular disorder in the Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) study.

  2017influential reference
• The Association Between Headaches and Temporomandibular Disorders is Confounded by Bruxism and Somatic Symptoms

  2017cited by this paper
• Self-management programmes in temporomandibular disorders: results from an international Delphi process.

  2016cited by this paper
• Myofascial Temporomandibular Disorder.

  2016cited by this paper
• Chronic Orofacial Pain and Behavioral Medicine.

  2016cited by this paper
• Impact of migraine on fibromyalgia symptoms

  2016cited by this paper
• The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache

  2016cited by this paper
• Specific and number of comorbidities are associated with increased levels of temporomandibular pain intensity and duration

  2015cited by this paper
• Prevalence of neck pain in migraine and tension-type headache: A population study

  2015influential reference
• Acute Migraine Treatment

  2015cited by this paper
• High-Definition and Non-invasive Brain Modulation of Pain and Motor Dysfunction in Chronic TMD.

  2015cited by this paper
• A potent and selective calcitonin gene-related peptide (CGRP) receptor antagonist, MK-8825, inhibits responses to nociceptive trigeminal activation: Role of CGRP in orofacial pain.

  2015cited by this paper
• Trigger Point Injections for Headache Disorders: Expert Consensus Methodology and Narrative Review

  2014cited by this paper
• Orofacial pain management: current perspectives

  2014cited by this paper
• Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†.

  2014influential reference
• Osteopenic consequences of botulinum toxin injections in the masticatory muscles: a pilot study.

  2014cited by this paper
• Expanding the taxonomy of the diagnostic criteria for temporomandibular disorders.

  2014cited by this paper
• Orofacial manual therapy improves cervical movement impairment associated with headache and features of temporomandibular dysfunction: a randomized controlled trial.

  2013cited by this paper
• Pearls and pitfalls in human pharmacological models of migraine: 30 years' experience

  2013cited by this paper
• Masticatory muscle sleep background electromyographic activity is elevated in myofascial temporomandibular disorder patients.

  2013cited by this paper
• Temporomandibular disorders, sleep bruxism, and primary headaches are mutually associated.

  2013cited by this paper
• Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study.

  2013influential reference
• Sleep bruxism and myofascial temporomandibular disorders: a laboratory-based polysomnographic investigation.

  2012cited by this paper
• Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization

  2011cited by this paper
• Temporomandibular Disorders Are Differentially Associated With Headache Diagnoses: A Controlled Study

  2011cited by this paper
• What is a systematic review?

  2011cited by this paper
• Effect of Treatment of Temporomandibular Disorders (TMD) in Patients with Cervicogenic Headache: A Single-Blind, Randomized Controlled Study

  2011cited by this paper
• Pharmacological management of orofacial pain

  2011cited by this paper
• Clinical findings and pain symptoms as potential risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

  2011cited by this paper
• Development of a brief and effective temporomandibular disorder pain screening questionnaire: reliability and validity.

  2011influential reference
• Migraine is the most prevalent primary headache in individuals with temporomandibular disorders.

  2010cited by this paper

• Central and Peripheral Sensitization in Temporomandibular Disorders: Proposed Mechanisms of Botulinum Toxin Therapy

  2026cites this paper
• 2025 Highlights in comorbidities and headache

  2026cites this paper
• Brief Diagnostic Criteria for Temporomandibular Disorders (Tmd): Enhancing Sensitivity in Diagnosing Headache Attributed to Tmd (A Multi-Centre Study).

  2026cites this paper
• OnabotulinumtoxinA to Prevent Chronic Migraine with Comorbid Bruxism: Real-World Data from the GRASP Study Group

  2025cites this paper
• In vivo immunological evaluation of indomethacin and omega-3 nanocapsules for the treatment of rheumatoid arthritis in the temporomandibular joints of rats.

  2025cites this paper